Skip to content

Analysis of therapeutic effects of high voltage long-term pulse radiofrequency and radiofrequency thermocoagulation in the treatment of postherpetic neuralgia

Analysis of therapeutic effects of high voltage long-term pulse radiofrequency and radiofrequency thermocoagulation in the treatment of postherpetic neuralgia

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081529
Enrollment
Unknown
Registered
2024-03-04
Start date
2024-03-05
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

High-voltage Long-duration pulse radio frequency group:Under the guidance of C-arm or CT, the radiofrequency needle is punctured to the location of the ganglia for pulsed radiofrequency. The mode is t
Radiofrequency thermocoagulation group:Under the guidance of C-arm or CT, the radiofrequency needle is punctured to the location of the ganglia for radiofrequency thermocoagulation, with a temperature

Sponsors

Jiangsu Subei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Age>50 years old; 2) Has a history of herpes zoster within the past month; 3) Persistent and intense pain, even after the skin injury is completely healed, there is still local skin pain hypersensitivity, numbness, or abnormal sensation, lasting for more than 3 months; 4) Pain did not pass standard medication treatment (antiepileptic drugs, antiepileptic drugs, antidepressants, opioid drugs); 5) The 24-hour Visual Analog Scale (VAS) pain score is = 5.

Exclusion criteria

Exclusion criteria: 1) Severe coagulation dysfunction or current anticoagulant therapy; 2) Severe liver and kidney dysfunction; 3) Severe cardiovascular and pulmonary diseases; 4) Intellectual inability to complete VAS or 36 Short Form Health Survey (SF-36) interventions.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
The Short-From-36 Health Survey;Pregabalin dosage;

Countries

China

Contacts

Public Contactyinghao song

Jiangsu Subei People's Hospital

425595226@qq.com+86 87373694

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026